A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
Vogelzang NJ, Karrison T, Stadler WM, Garcia J, Cohn H, Kugler J, Troeger T, Giannone L, Arrieta R, Ratain MJ, Vokes EE.
Vogelzang NJ, et al. Among authors: karrison t.
Cancer. 2004 Jan 1;100(1):65-71. doi: 10.1002/cncr.11867.
Cancer. 2004.
PMID: 14692025
Free article.
Clinical Trial.